Stay updated on Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial page.

Latest updates to the Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous notices including the government funding lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide funding/operating-status notice was added and the page version updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedNew UI items include a glossary display and the label Last Update Submitted that Met QC Criteria, along with No FEAR Act Data and Revision: v3.4.0. The older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 have been removed.SummaryDifference0.1%

- Check42 days agoChange Detected- The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check64 days agoChange DetectedThe Study Details page now lists a substantially expanded set of study locations across the United States, Canada, Europe, and other regions, indicating more sites where participants may enroll.SummaryDifference3%

- Check85 days agoChange DetectedThe page revision was updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial page.